Last year, the 4th Edition of this Conference focused on addressing the gaps between early-stage biomarker development and the commercialization stage of biomarkers. Leading industry and academic experts shared their case studies focusing on advancements in the companion diagnostics area. Designed to deliver a forward-looking perspective on the opportunities and challenges impacting market growth for the biomarker industry, the conference will focus on Biomarker Discovery & exploratory Biomarkers and application of biomarkers in Immuno-oncology, neurology and inflammatory diseases.
30+ experts from academia and industry will be presenting their current work in Biomarkers, Latest updates on regulatory guidelines and approvals, Cancer biomarker validation for clinical application, Biomarkers and Personalized Medicine, Impact of Big data in translational biomarker research and Future of Companion Diagnostics
Opportunity to develop long-lasting business relationships and networking opportunities with researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies, Universities, and Research institutes.
Over 20 presentations, round-tables, and panel discussions focused on the key opportunities and challenges in biomarker research, from precision medicine and companion diagnostics through to digital biomarkers and clinical trials.
This two-day event will invite 100+ biomarker discovery professionals, 20+ expert speakers and 15+ solution/technology providers to a unique platform to deliver niche buyer-seller ecosystem in the biomarker Industry.
Researchers, Scientists & Clinicians who are active in Biomarker discovery, Translational research, Clinical Biomarker, Imaging Biomarkers & Companion Diagnostics.
Biomarker Discovery & exploratory Biomarkers, Biomarkers and Personalized Medicine, Impact of Big data in translational biomarker research, Future of Companion Diagnostics